China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
2.430
+0.140 (6.11%)
Apr 28, 2025, 9:41 AM EDT - Market open

China SXT Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Apr '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2016 - 2019
Market Capitalization
3313112916
Upgrade
Market Cap Growth
45.88%-67.93%-73.95%-60.15%83.78%-89.90%
Upgrade
Enterprise Value
23-7214199
Upgrade
Last Close Price
2.2913.4456.721120.007360.008961.60
Upgrade
PE Ratio
0.11-----
Upgrade
PS Ratio
0.350.491.504.375.973.01
Upgrade
PB Ratio
0.070.070.200.691.791.65
Upgrade
P/TBV Ratio
2.100.070.200.691.791.66
Upgrade
P/FCF Ratio
---55.27-29.44
Upgrade
P/OCF Ratio
---42.40-16.62
Upgrade
EV/Sales Ratio
12.58-0.795.373.931.77
Upgrade
EV/EBITDA Ratio
3.37-----
Upgrade
EV/EBIT Ratio
3.46-----
Upgrade
EV/FCF Ratio
---67.88-17.33
Upgrade
Debt / Equity Ratio
0.660.270.610.650.760.72
Upgrade
Debt / EBITDA Ratio
1.44-----
Upgrade
Debt / FCF Ratio
---52.20-12.75
Upgrade
Asset Turnover
0.080.070.060.080.170.26
Upgrade
Inventory Turnover
1.311.981.881.101.602.07
Upgrade
Quick Ratio
1.291.511.311.141.001.26
Upgrade
Current Ratio
1.401.601.351.311.251.60
Upgrade
Return on Equity (ROE)
57.63%-21.65%-38.15%-35.42%-21.67%-100.33%
Upgrade
Return on Assets (ROA)
18.15%-4.96%-10.42%-9.53%-4.88%-4.28%
Upgrade
Return on Capital (ROIC)
24.65%-6.34%-12.93%-11.73%-6.20%-5.58%
Upgrade
Return on Capital Employed (ROCE)
43.20%-----
Upgrade
Earnings Yield
18.39%-326.13%-200.33%-50.43%-9.63%-66.24%
Upgrade
FCF Yield
-8.61%-203.68%-5.11%1.81%-4.94%3.40%
Upgrade
Buyback Yield / Dilution
-378.48%-224.91%----
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q